Article
Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia
20 Feb 2017
Abstract excerpt
BACKGROUND: The majority of individuals with acute myeloid leukemia (AML) respond to initial chemotherapy and achieve a complete remission, yet only a minority experience long-term survival because a large proportion of patients eventually relapse with therapy-resistant disease. Relapse therefore represents a central problem in the treatment of AML. Despite this, and in contrast to the extensive knowledge about...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
